Platelet glycoproteinⅡb/Ⅲa receptor antagonist:eptifibatide;
血小板糖蛋白Ⅱb/Ⅲa受体拮抗药依替巴肽
Eptifibatide or tirofiban was predominantly initiated in the catheter laboratory before the intervention.
目的探讨依替巴肽与替罗非班在急性冠状动脉综合征(ACS)介入治疗中的临床疗效和安全性。
本网站所收集内容来自网友分享仅供参考,实际请以各学校实际公布信息为主!内容侵权及错误投诉:1553292129@qq.com
CopyRight © 2020-2024 优校网[www.youxiaow.com]版权所有 All Rights Reserved. ICP备案号:浙ICP备2024058711号